OB: Labor and Birth Complications
NCLEX Questions And Answers
In jplanning jfor jhome jcare jof ja jwoman jwith jpreterm jlabor, jwhich jconcern jmust jthe jnurse jaddress?
a. jNursing jassessments jwill jbe jdifferent jfrom jthose jdone jin jthe jhospital jsetting.
b. jRestricted jactivity jand jmedications jwill jbe jnecessary jto jprevent jrecurrence jof jpreterm jlabor.
c. jProlonged jbed jrest jmay jcause jnegative jphysiologic jeffects.
d. jHome jhealth jcare jproviders jwill jbe jnecessary. j- jAnswer j- jC
Prolonged jbed jrest jmay jcause jadverse jeffects jsuch jas jweight jloss, jloss jof jappetite, jmuscle jwasting,
jweakness, jbone jdemineralization, jdecreased jcardiac joutput, jrisk jfor jthrombophlebitis, jalteration jin
jbowel jfunctions, jsleep jdisturbance, jand jprolonged jpostpartum jrecovery. jNursing jassessments jwill jdiffer
jsomewhat jfrom jthose jperformed jin jthe jacute jcare jsetting, jbut jthis jis jnot jthe jconcern jthat jneeds jto jbe
jaddressed. jRestricted jactivity jand jmedication jmay jprevent jpreterm jlabor, jbut jnot jin jall jwomen. jIn
jaddition, jthe jplan jof jcare jis jindividualized jto jmeet jthe jneeds jof jeach jwoman. jMany jwomen jwill jreceive
jhome jhealth jnurse jvisits, jbut jcare jis jindividualized jfor jeach jwoman.
In jevaluating jthe jeffectiveness jof jmagnesium jsulfate jfor jthe jtreatment jof jpreterm jlabor, jwhat jfinding
jwould jalert jthe jnurse jto jpossible jside jeffects?
a. jUrine joutput jof j160 jmL jin j4 jhours
b. jDeep jtendon jreflexes j2+ jand jno jclonus
c. jRespiratory jrate jof j16 jbreaths/min
d. jSerum jmagnesium jlevel jof j10 jmg/dL j- jAnswer j- jD
The jtherapeutic jrange jfor jmagnesium jsulfate jmanagement jis j5 jto j8 jmg/dL. jA jserum jmagnesium jlevel jof
j10 jmg/dL jcould jlead jto jsigns jand jsymptoms jof jmagnesium jtoxicity, jincluding joliguria jand jrespiratory
jdistress. jUrine joutput jof j160 jmL jin j4 jhours, jdeep jtendon jreflexes j2+ jwith jno jclonus, jand jrespiratory jrate
jof j16 jbreaths/min jare jnormal jfindings.
A jwoman jin jpreterm jlabor jat j30 jweeks jof jgestation jreceives jtwo j12-mg jdoses jof jbetamethasone
jintramuscularly. jThe jpurpose jof jthis jpharmacologic jtreatment jis jto:
a. jStimulate jfetal jsurfactant jproduction.
b. jReduce jmaternal jand jfetal jtachycardia jassociated jwith jritodrine jadministration.
c. jSuppress juterine jcontractions.
, d. jMaintain jadequate jmaternal jrespiratory jeffort jand jventilation jduring jmagnesium jsulfate jtherapy. j-
jAnswer j- jA
Antenatal jglucocorticoids jgiven jas jintramuscular jinjections jto jthe jmother jaccelerate jfetal jlung jmaturity.
jInderal jwould jbe jgiven jto jreduce jthe jeffects jof jritodrine jadministration. jBetamethasone jhas jno jeffect
jon juterine jcontractions. jCalcium jgluconate jwould jbe jgiven jto jreverse jthe jrespiratory jdepressive jeffects
jof jmagnesium jsulfate jtherapy.
A jwoman jat j26 jweeks jof jgestation jis jbeing jassessed jto jdetermine jwhether jshe jis jexperiencing jpreterm
jlabor. jWhat jfinding jindicates jthat jpreterm jlabor jis joccurring?
a. jEstriol jis jnot jfound jin jmaternal jsaliva.
b. jIrregular, jmild juterine jcontractions jare joccurring jevery j12 jto j15 jminutes.
c. jFetal jfibronectin jis jpresent jin jvaginal jsecretions.
d. jThe jcervix jis jeffacing jand jdilated jto j2 jcm. j- jAnswer j- jD
Cervical jchanges jsuch jas jshortened jendocervical jlength, jeffacement, jand jdilation jare jpredictors jof
jimminent jpreterm jlabor. jChanges jin jthe jcervix jaccompanied jby jregular jcontractions jindicate jlabor jat
jany jgestation. jEstriol jis ja jform jof jestrogen jproduced jby jthe jfetus jthat jis jpresent jin jplasma jat j9 jweeks jof
jgestation. jLevels jof jsalivary jestriol jhave jbeen jshown jto jincrease jbefore jpreterm jbirth. jIrregular, jmild
jcontractions jthat jdo jnot jcause jcervical jchange jare jnot jconsidered ja jthreat. jThe jpresence jof jfetal
jfibronectin jin jvaginal jsecretions jbetween j24 jand j36 jweeks jof jgestation jcould jpredict jpreterm jlabor, jbut
jit jhas jonly ja j20% jto j40% jpositive jpredictive jvalue. jOf jmore jimportance jare jother jphysiologic jclues jof
jpreterm jlabor jsuch jas jcervical jchanges.
A jprimigravida jat j40 jweeks jof jgestation jis jhaving juterine jcontractions jevery j1.5 jto j2 jminutes jand jsays
jthat jthey jare jvery jpainful. jHer jcervix jis jdilated j2 jcm jand jhas jnot jchanged jin j3 jhours. jThe jwoman jis jcrying
jand jwants jan jepidural. jWhat jis jthe jlikely jstatus jof jthis jwoman's jlabor?
a. jShe jis jexhibiting jhypotonic juterine jdysfunction.
b. jShe jis jexperiencing ja jnormal jlatent jstage.
c. jShe jis jexhibiting jhypertonic juterine jdysfunction.
d. jShe jis jexperiencing jpelvic jdystocia. j- jAnswer j- jC
Women jwho jexperience jhypertonic juterine jdysfunction, jor jprimary jdysfunctional jlabor, joften jare
janxious jfirst-time jmothers jwho jare jhaving jpainful jand jfrequent jcontractions jthat jare jineffective jat
jcausing jcervical jdilation jor jeffacement jto jprogress. jWith jhypotonic juterine jdysfunction, jthe jwoman
jinitially jmakes jnormal jprogress jinto jthe jactive jstage jof jlabor; jthen jthe jcontractions jbecome jweak jand
jinefficient jor jstop jaltogether. jThe jcontraction jpattern jseen jin jthis jwoman jsignifies jhypertonic juterine
jactivity. jTypically juterine jactivity jin jthis jphase joccurs jat j4- jto j5-minute jintervals jlasting j30 jto j45 jseconds.
jPelvic jdystocia jcan joccur jwhenever jcontractures jof jthe jpelvic jdiameters jreduce jthe jcapacity jof jthe jbony
jpelvis, jincluding jthe jinlet, jmidpelvis, joutlet, jor jany jcombination jof jthese jplanes.
Which jassessment jis jleast jlikely jto jbe jassociated jwith ja jbreech jpresentation?
NCLEX Questions And Answers
In jplanning jfor jhome jcare jof ja jwoman jwith jpreterm jlabor, jwhich jconcern jmust jthe jnurse jaddress?
a. jNursing jassessments jwill jbe jdifferent jfrom jthose jdone jin jthe jhospital jsetting.
b. jRestricted jactivity jand jmedications jwill jbe jnecessary jto jprevent jrecurrence jof jpreterm jlabor.
c. jProlonged jbed jrest jmay jcause jnegative jphysiologic jeffects.
d. jHome jhealth jcare jproviders jwill jbe jnecessary. j- jAnswer j- jC
Prolonged jbed jrest jmay jcause jadverse jeffects jsuch jas jweight jloss, jloss jof jappetite, jmuscle jwasting,
jweakness, jbone jdemineralization, jdecreased jcardiac joutput, jrisk jfor jthrombophlebitis, jalteration jin
jbowel jfunctions, jsleep jdisturbance, jand jprolonged jpostpartum jrecovery. jNursing jassessments jwill jdiffer
jsomewhat jfrom jthose jperformed jin jthe jacute jcare jsetting, jbut jthis jis jnot jthe jconcern jthat jneeds jto jbe
jaddressed. jRestricted jactivity jand jmedication jmay jprevent jpreterm jlabor, jbut jnot jin jall jwomen. jIn
jaddition, jthe jplan jof jcare jis jindividualized jto jmeet jthe jneeds jof jeach jwoman. jMany jwomen jwill jreceive
jhome jhealth jnurse jvisits, jbut jcare jis jindividualized jfor jeach jwoman.
In jevaluating jthe jeffectiveness jof jmagnesium jsulfate jfor jthe jtreatment jof jpreterm jlabor, jwhat jfinding
jwould jalert jthe jnurse jto jpossible jside jeffects?
a. jUrine joutput jof j160 jmL jin j4 jhours
b. jDeep jtendon jreflexes j2+ jand jno jclonus
c. jRespiratory jrate jof j16 jbreaths/min
d. jSerum jmagnesium jlevel jof j10 jmg/dL j- jAnswer j- jD
The jtherapeutic jrange jfor jmagnesium jsulfate jmanagement jis j5 jto j8 jmg/dL. jA jserum jmagnesium jlevel jof
j10 jmg/dL jcould jlead jto jsigns jand jsymptoms jof jmagnesium jtoxicity, jincluding joliguria jand jrespiratory
jdistress. jUrine joutput jof j160 jmL jin j4 jhours, jdeep jtendon jreflexes j2+ jwith jno jclonus, jand jrespiratory jrate
jof j16 jbreaths/min jare jnormal jfindings.
A jwoman jin jpreterm jlabor jat j30 jweeks jof jgestation jreceives jtwo j12-mg jdoses jof jbetamethasone
jintramuscularly. jThe jpurpose jof jthis jpharmacologic jtreatment jis jto:
a. jStimulate jfetal jsurfactant jproduction.
b. jReduce jmaternal jand jfetal jtachycardia jassociated jwith jritodrine jadministration.
c. jSuppress juterine jcontractions.
, d. jMaintain jadequate jmaternal jrespiratory jeffort jand jventilation jduring jmagnesium jsulfate jtherapy. j-
jAnswer j- jA
Antenatal jglucocorticoids jgiven jas jintramuscular jinjections jto jthe jmother jaccelerate jfetal jlung jmaturity.
jInderal jwould jbe jgiven jto jreduce jthe jeffects jof jritodrine jadministration. jBetamethasone jhas jno jeffect
jon juterine jcontractions. jCalcium jgluconate jwould jbe jgiven jto jreverse jthe jrespiratory jdepressive jeffects
jof jmagnesium jsulfate jtherapy.
A jwoman jat j26 jweeks jof jgestation jis jbeing jassessed jto jdetermine jwhether jshe jis jexperiencing jpreterm
jlabor. jWhat jfinding jindicates jthat jpreterm jlabor jis joccurring?
a. jEstriol jis jnot jfound jin jmaternal jsaliva.
b. jIrregular, jmild juterine jcontractions jare joccurring jevery j12 jto j15 jminutes.
c. jFetal jfibronectin jis jpresent jin jvaginal jsecretions.
d. jThe jcervix jis jeffacing jand jdilated jto j2 jcm. j- jAnswer j- jD
Cervical jchanges jsuch jas jshortened jendocervical jlength, jeffacement, jand jdilation jare jpredictors jof
jimminent jpreterm jlabor. jChanges jin jthe jcervix jaccompanied jby jregular jcontractions jindicate jlabor jat
jany jgestation. jEstriol jis ja jform jof jestrogen jproduced jby jthe jfetus jthat jis jpresent jin jplasma jat j9 jweeks jof
jgestation. jLevels jof jsalivary jestriol jhave jbeen jshown jto jincrease jbefore jpreterm jbirth. jIrregular, jmild
jcontractions jthat jdo jnot jcause jcervical jchange jare jnot jconsidered ja jthreat. jThe jpresence jof jfetal
jfibronectin jin jvaginal jsecretions jbetween j24 jand j36 jweeks jof jgestation jcould jpredict jpreterm jlabor, jbut
jit jhas jonly ja j20% jto j40% jpositive jpredictive jvalue. jOf jmore jimportance jare jother jphysiologic jclues jof
jpreterm jlabor jsuch jas jcervical jchanges.
A jprimigravida jat j40 jweeks jof jgestation jis jhaving juterine jcontractions jevery j1.5 jto j2 jminutes jand jsays
jthat jthey jare jvery jpainful. jHer jcervix jis jdilated j2 jcm jand jhas jnot jchanged jin j3 jhours. jThe jwoman jis jcrying
jand jwants jan jepidural. jWhat jis jthe jlikely jstatus jof jthis jwoman's jlabor?
a. jShe jis jexhibiting jhypotonic juterine jdysfunction.
b. jShe jis jexperiencing ja jnormal jlatent jstage.
c. jShe jis jexhibiting jhypertonic juterine jdysfunction.
d. jShe jis jexperiencing jpelvic jdystocia. j- jAnswer j- jC
Women jwho jexperience jhypertonic juterine jdysfunction, jor jprimary jdysfunctional jlabor, joften jare
janxious jfirst-time jmothers jwho jare jhaving jpainful jand jfrequent jcontractions jthat jare jineffective jat
jcausing jcervical jdilation jor jeffacement jto jprogress. jWith jhypotonic juterine jdysfunction, jthe jwoman
jinitially jmakes jnormal jprogress jinto jthe jactive jstage jof jlabor; jthen jthe jcontractions jbecome jweak jand
jinefficient jor jstop jaltogether. jThe jcontraction jpattern jseen jin jthis jwoman jsignifies jhypertonic juterine
jactivity. jTypically juterine jactivity jin jthis jphase joccurs jat j4- jto j5-minute jintervals jlasting j30 jto j45 jseconds.
jPelvic jdystocia jcan joccur jwhenever jcontractures jof jthe jpelvic jdiameters jreduce jthe jcapacity jof jthe jbony
jpelvis, jincluding jthe jinlet, jmidpelvis, joutlet, jor jany jcombination jof jthese jplanes.
Which jassessment jis jleast jlikely jto jbe jassociated jwith ja jbreech jpresentation?
